Correction: Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Registry comparison of ATG and alemtuzumab for in vivo T-cell depletion in GVHD prophylaxis among unrelated-donor allo-HCT recipients with AML and intermediate-intensity conditioning, on behalf of the EBMT Acute Leukemia Working Party

  • By

  • Jesús Duque-Afonso

  • Jürgen Finke

  • Allain-Thibeault Ferhat

  • Jacques-Emmanuel Galimard

  • Francesca Kinsella

  • Deborah Richardson

  • Friedrich Stölzel

  • Eleni Tholouli

  • Caroline Besley

  • Matthias Eder

  • Emma Nicholson

  • Robert Zeiser

  • Adrian Bloor

  • Charles Crawley

  • Katherine Clesham

  • Jennifer Byrne

  • Patrick Medd

  • Elisa Sala

  • Caroline Pabst

  • Jan Vydra

  • Eva Maria Wagner-Drouet

  • Alain Gadisseur

  • Alexandros Spyridonidis

  • Eolia Brissot

  • Arnon Nagler

  • Mohamad Mohty

  • Fabio Ciceri

  • October 23, 2026

Share

Objective:

To correct an author-name error in the article.

Approach:
  • Correction: The author’s name, Allain-Thibeault Ferhat, was incorrectly published as Thibeault Ferhat-Berland.
Key Findings:
  • A correction was issued for the article.
Interpretation:

The correction concerns the author’s name.

Conclusion:

The correction was published online on 10 September 2026.

Sources:

Original Source(s)

Correction: Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party

  • by Jesús Duque-Afonso, Jürgen Finke, Allain-Thibeault Ferhat, Jacques-Emmanuel Galimard, Francesca Kinsella, Deborah Richardson, Friedrich Stölzel, Eleni Tholouli, Caroline Besley, Matthias Eder, Emma Nicholson, Robert Zeiser, Adrian Bloor, Charles Crawley, Katherine Clesham, Jennifer Byrne, Patrick Medd, Elisa Sala, Caroline Pabst, Jan Vydra, Eva Maria Wagner-Drouet, Alain Gadisseur, Alexandros Spyridonidis, Eolia Brissot, Arnon Nagler, Mohamad Mohty, Fabio Ciceri

  • October 23, 2026

Related Content

Author Correction: Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis

Retroperitoneal Spindle Cell Liposarcoma Presenting With Bowel Obstruction

  • October 20, 2026

Rising Endometrial Cancer Incidence: Clinical Priorities in Evaluation and Management

The increasing incidence of endometrial cancer is placing greater emphasis on timely recognition of abnormal uterine bleeding, individualized risk assessment and prompt diagnostic evaluation.

  • by

  • October 21, 2026

  • 6 min